Munich Leukemia Laboratory (Germany)

Recent papers from Munich Leukemia Laboratory (Germany)

1. Deciphering the Dynamics of Leukemogenic Transformation from Clonal Hematopoiesis in Congenital Neutropenia2026
2. Distinct Consequences of BCOR and BCORL1 Mutations in Myeloid Neoplasms and Bone Marrow FailureAmerican Journal of Hematology · 2026
3. Frequent FLT3 and IDH co-mutations in acute myeloid leukemia with mutated NPM1, NUP98 rearrangement, and KMT2A partial tandem duplication but not rearrangement: potential for combined targeted therapyHaematologica · 2026
4. Harmonizing flow‐based quantification of CD19 ‐directed CAR ‐T cells: Results from a multi‐center interlaboratory comparisonCytometry Part B Clinical Cytometry · 2026
5. Mutant calreticulin-driven myeloproliferative neoplasms favour the emergence of TIGIT-positive NK cellsLeukemia · 2026
6. Triterpenoid Exposure and HO-1 Blockade Sensitize Neoplastic Mast Cells Against Midostaurin and AvapritinibCells · 2026
7. Clonal Haematopoiesis of Indeterminate Potential and Mortality in Coronary Artery DiseaseAtherosclerosis · 2026
8. Colchicine Reverses Inflammatory Signatures in Chip-Positive Coronary Disease: The Colchip TrialAtherosclerosis · 2026
9. Validation of the International Working Group 2023 response criteria for higher risk myelodysplastic syndromes/neoplasms using the International Consortium for Myelodysplastic Syndromes VALIDATE database and a randomized phase III trialHaematologica · 2026
10. Functional Classification of Monoallelic TP53 Mutations Refines Prognostic Stratification in Myelodysplastic NeoplasmsBlood · 2026
11. Two cases of an imatinib-sensitive PRKG2::PDGFRA-positive chronic myeloid neoplasm with basophiliaLeukemia · 2026
12. Unbiased, systematic surfaceome profiling of Acute Leukemia to identify novel immunotherapy targets2026
13. Early deep response to cilta-cel as 2nd CAR T-Cell therapy after CELMoD-based bridging for advanced multiple myelomaAnnals of Hematology · 2026
14. Elevated expression of heme metabolism genes as a favorable biomarker in SF3B1 -mutated myelodysplastic neoplasmsLeukemia & lymphoma/Leukemia and lymphoma · 2026
15. MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignanciesBlood · 2026
16. Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasmsLeukemia · 2026
17. The benchmark illusion: on the curious underestimation of AI and the uncertainty of its creators’ gold standardsEClinicalMedicine · 2026
18. The machine‐learning classifier ALLCatchR2 identifies 20 T‐ALL subtypes across cohorts and age groupsHemaSphere · 2026
19. Machine learning provides individualized prediction of outcomes after first complete remission without allo‐HSCT consolidation in adult acute myeloid leukemia—A HARMONY studyHemaSphere · 2026
20. ESCCA recommendations for managing measurement uncertainty in ISO 15189 accredited flow cytometry laboratories: A risk‐based approachCytometry Part B Clinical Cytometry · 2026